penicillin v and cefpodoxime proxetil

penicillin v has been researched along with cefpodoxime proxetil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavanet, P; Gouyon, JB; Guetat, F; Portier, H1
Chavanet, P; Grey, PC; Ichou, F; Kisterman, JP; Portier, H; Safran, C; Waldner-Combernoux, A1
Dajani, AS; Kessler, SL; Mendelson, R; Todd, WM; Uden, DL1
Fiessinger, S; Gehanno, P; Ichou, F; Pelc, A; Portier, H1

Trials

4 trial(s) available for penicillin v and cefpodoxime proxetil

ArticleYear
Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl E

    Topics: Adolescent; Adult; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Pilot Projects; Prodrugs; Streptococcus pyogenes; Tonsillitis

1990
Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
    Scandinavian journal of infectious diseases, 1994, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefpodoxime Proxetil; Ceftizoxime; Child; Drug Administration Schedule; Female; France; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Prodrugs; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis

1994
Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
    The Pediatric infectious disease journal, 1993, Volume: 12, Issue:4

    Topics: Adolescent; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Single-Blind Method; Statistics as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome

1993
Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
    PharmacoEconomics, 1996, Volume: 10, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Drug Therapy, Combination; Family Practice; France; Humans; Penicillin V; Pharyngitis; Prodrugs; Recurrence; Tonsillitis; Treatment Outcome

1996